Literature DB >> 8670226

Native lipoproteins inhibit platelet activation induced by oxidized lipoproteins.

Y Takahashi1, H Chiba, K Matsuno, H Akita, S P Hui, H Nagasaka, H Nakamura, K Kobayashi, N N Tandon, G A Jamieson.   

Abstract

Copper-catalyzed oxidation of low-density lipoproteins (LDL) (0.8 g protein/l LDL, 20 mumol/l CuSo4, 37 degrees C) resulted in the formation of thiobarbituric reactive substances that was substantially completed at 24 hrs whereas their formation from high-density lipoproteins (HDL) plateaued at only 25% of that amount after 8 hrs. The oxidized lipoproteins induced aggregation and increases in [Ca2+]i in washed platelets, but not in platelet-rich plasma, and these activating effects were not inhibited by aspirin or EGTA but were inhibited by both of the native lipoproteins. These results show that oxidized HDL, like oxidized LDL, have platelet activating ability and suggest that the native lipoproteins may play a crucial role in preventing the oxidized lipoprotein-mediated platelet activation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8670226     DOI: 10.1006/bbrc.1996.0765

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Regulation of platelet function by class B scavenger receptors in hyperlipidemia.

Authors:  Alejandro Zimman; Eugene A Podrez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

2.  Low concentration of oxidized low density lipoprotein suppresses platelet reactivity in vitro: an intracellular study.

Authors:  Duen-Suey Chou; George Hsiao; Ming-Yi Shen; Tsorng-Harn Fong; Chien-Huang Lin; Tzeng-Fu Chen; Joen-Rong Sheu
Journal:  Lipids       Date:  2004-05       Impact factor: 1.880

3.  Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI.

Authors:  Manojkumar Valiyaveettil; Niladri Kar; Mohammad Z Ashraf; Tatiana V Byzova; Maria Febbraio; Eugene A Podrez
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

4.  Vasculitis, Atherosclerosis, and Altered HDL Composition in Heme-Oxygenase-1-Knockout Mice.

Authors:  Kazunobu Ishikawa; Mohamad Navab; Aldons J Lusis
Journal:  Int J Hypertens       Date:  2012-02-20       Impact factor: 2.420

5.  Secretory phospholipase A2 modified HDL rapidly and potently suppresses platelet activation.

Authors:  Sanja Curcic; Michael Holzer; Lisa Pasterk; Eva Knuplez; Thomas O Eichmann; Saša Frank; Robert Zimmermann; Rudolf Schicho; Akos Heinemann; Gunther Marsche
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

6.  Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics.

Authors:  Si-Wen Gui; Yi-Yun Liu; Xiao-Gang Zhong; Xinyu Liu; Peng Zheng; Jun-Cai Pu; Jian Zhou; Jian-Jun Chen; Li-Bo Zhao; Lan-Xiang Liu; Guowang Xu; Peng Xie
Journal:  Neuropsychiatr Dis Treat       Date:  2018-06-06       Impact factor: 2.570

7.  Native high density lipoproteins (HDL) interfere with platelet activation induced by oxidized low density lipoproteins (OxLDL).

Authors:  Sigrun Badrnya; Alice Assinger; Ivo Volf
Journal:  Int J Mol Sci       Date:  2013-05-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.